Kindeva Drug Delivery has joined Pharma.Aero’s Life Science Manufacturers Advisory Platform (LMAP), reinforcing the collective voice of manufacturers shaping the future of healthcare logistics.
With more than a century of experience in drug delivery innovation, Kindeva has evolved from a drug–device manufacturer into a full-service contract development and manufacturing organization (CDMO). Its expertise spans complex combination products, supported by deep regulatory knowledge and a long-standing track record of guiding products from development through to market.
Becoming a member of PharmaAero enables Kindeva to shape best practices for pharmaceutical logistics. The involvement opens valuable opportunities for meaningful contributions to the industry as well as working with other members to advance our knowledge, connect with key stakeholders and ultimately improve patient outcomes.
With capabilities spanning pulmonary & nasal, injectable, and transdermal delivery formats, Kindeva supports clients from early-stage feasibility through commercial-scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Operating from state-of-the-art facilities in the U.S. and U.K., Kindeva serves a worldwide client base with a commitment to quality and innovation.
As life sciences supply chains become more integrated and increasingly complex, insights from organizations operating at the intersection of product development, manufacturing, and regulatory compliance are essential to advancing shared standards and practical solutions. Through LMAP, Kindeva will actively contribute to industry discussions and collaborative projects, supporting Pharma.Aero’s mission to drive innovation, enable meaningful partnerships, and strengthen the resilience and performance of global healthcare logistics.